Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Overview

CASI is a NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products.

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
131 portfolio companies: Veracyte, UpDoc, Zura Bio and 128 more

People

Chunhua Wang
Executive Officer
Wei Gao
Executive Officer
Hai Huang
Executive Officer
Kun Qian
Executive Officer
Alexander Zukiwski
Executive Officer
Wei Larry Zhang
Executive Officer
Wei-Wu He
Director
David Cory
Executive Officer, Director
Alexander Wu
Director
Zhenbo Su
Director
Thomas Folinsbee
Director
Xuebo Zeng
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Beijing China
HQ
Beijing, China
1000-5000 est. staff
601 Gateway Boulevard, Suite 1250, South San Francisco, California
company site

Financials

Est. Annual Revenue
$15M
2025
Total raised
$20M
Latest round
Debt Financing
Funding rounds
2
Revenue
Estimate Low-high range Modelled from public signals, not audited accounts - read it as an order of magnitude.
Est. Annual Revenue, 2023 — 2025
YearEstimateLowHigh
2023 $62.5M $25M $100M
2025 $15M $5M $25M
Funding rounds
Round Announced Amount
Debt Financing 2025 $5M Details
Venture - Series Unknown 2024 $15M Details